Potential Supervisor: Daniel Fürstenau
Level: Master thesis

Background

Digital health applications (DiGA) are becoming increasingly important in healthcare provision, yet their actual medical and economic effects vary considerably. Despite clear requirements set by the BfArM, it remains unclear how individual DiGA differ in terms of effectiveness, risks, and side effects. The thesis aims to compare different applications based on available and, if necessary, expanded data in order to transparently assess their medical outcomes and economic impacts and thereby contribute to the evidence-based further development of digital healthcare.

References

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). (2023). Das Fast-Track-Verfahren für digitale Gesundheitsanwendungen (DiGA) nach § 139e SGB V – Leitfaden.

Fürstenau, D., Gersch, M. & Schreiter, S. Digital Therapeutics (DTx). Bus Inf Syst Eng 65, 349–360 (2023). https://doi.org/10.1007/s12599-023-00804-z